These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11911860)

  • 1. Neuroprotective effects of the sodium channel blocker RS100642 and attenuation of ischemia-induced brain seizures in the rat.
    Williams AJ; Tortella FC
    Brain Res; 2002 Apr; 932(1-2):45-55. PubMed ID: 11911860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sodium channel blocker RS100642 reverses down-regulation of the sodium channel alpha-subunit Na(v) 1.1 expression caused by transient ischemic brain injury in rats.
    Yao C; Williams AJ; Lu XC; Price RA; Cunningham BS; Berti R; Tortella FC; Dave JR
    Neurotox Res; 2003; 5(4):245-53. PubMed ID: 12835116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotection assessment by topographic electroencephalographic analysis: effects of a sodium channel blocker to reduce polymorphic delta activity following ischaemic brain injury in rats.
    Williams AJ; Lu XC; Hartings JA; Tortella FC
    Fundam Clin Pharmacol; 2003 Oct; 17(5):581-93. PubMed ID: 14703719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electroencephalogram analysis and neuroprotective profile of the N-acetylated-alpha-linked acidic dipeptidase inhibitor, GPI5232, in normal and brain-injured rats.
    Williams AJ; Lu XM; Slusher B; Tortella FC
    J Pharmacol Exp Ther; 2001 Oct; 299(1):48-57. PubMed ID: 11561062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use-dependent sodium channel blocker mexiletine is neuroprotective against global ischemic injury.
    Hewitt KE; Stys PK; Lesiuk HJ
    Brain Res; 2001 Apr; 898(2):281-7. PubMed ID: 11306014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel voltage-sensitive Na(+) and Ca(2+) channel blocker, NS-7, prevents suppression of cyclic AMP-dependent protein kinase and reduces infarct area in the acute phase of cerebral ischemia in rat.
    Tanaka K; Ito D; Suzuki S; Dembo T; Kosakai A; Fukuuchi Y
    Brain Res; 2002 Jan; 924(1):98-108. PubMed ID: 11744000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of gabapentin and ethosuximide for treatment of acute nonconvulsive seizures following ischemic brain injury in rats.
    Williams AJ; Bautista CC; Chen RW; Dave JR; Lu XC; Tortella FC; Hartings JA
    J Pharmacol Exp Ther; 2006 Sep; 318(3):947-55. PubMed ID: 16728590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to improve post-stroke behavioral recovery in aged subjects.
    Buga AM; Bălşeanu A; Popa-Wagner A; Mogoantă L
    Rom J Morphol Embryol; 2009; 50(4):559-82. PubMed ID: 19942950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic time window and dose dependence of neuroprotective effects of sodium orthovanadate following transient middle cerebral artery occlusion in rats.
    Hasegawa Y; Morioka M; Hasegawa S; Matsumoto J; Kawano T; Kai Y; Yano S; Fukunaga K; Kuratsu J
    J Pharmacol Exp Ther; 2006 May; 317(2):875-81. PubMed ID: 16461588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat.
    Zhao Z; Cheng M; Maples KR; Ma JY; Buchan AM
    Brain Res; 2001 Aug; 909(1-2):46-50. PubMed ID: 11478919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice.
    Yu GL; Wei EQ; Zhang SH; Xu HM; Chu LS; Zhang WP; Zhang Q; Chen Z; Mei RH; Zhao MH
    Pharmacology; 2005 Jan; 73(1):31-40. PubMed ID: 15452361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke.
    Brdon J; Kaiser S; Hagemann F; Zhao Y; Culman J; Gohlke P
    J Hypertens; 2007 Jan; 25(1):187-96. PubMed ID: 17143191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metyrapone, an inhibitor of glucocorticoid production, reduces brain injury induced by focal and global ischemia and seizures.
    Smith-Swintosky VL; Pettigrew LC; Sapolsky RM; Phares C; Craddock SD; Brooke SM; Mattson MP
    J Cereb Blood Flow Metab; 1996 Jul; 16(4):585-98. PubMed ID: 8964797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ziprasidone attenuates brain injury after focal cerebral ischemia induced by middle cerebral artery occlusion in rats.
    Kam KY; Jalin AM; Choi YW; Kaengkan P; Park SW; Kim YH; Kang SG
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):69-74. PubMed ID: 22627197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of ischemic reperfusion injury in the rat neocortex by a potent antioxidant mexiletine.
    Chang CZ; Winardi D; Loh JK; Kung SS; Howng SL; Jeng AY; Kwan AL
    Acta Neurochir (Wien); 2002 Feb; 144(2):189-93; discussion 193. PubMed ID: 11862520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats.
    Shi QJ; Wang H; Liu ZX; Fang SH; Song XM; Lu YB; Zhang WP; Sa XY; Ying HZ; Wei EQ
    Neuroscience; 2015 Apr; 291():53-69. PubMed ID: 25681271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective actions in vivo and electrophysiological actions in vitro of 202W92.
    Caputi L; Hainsworth AH; Lavaroni F; Leach MJ; McNaughton NC; Mercuri NB; Randall AD; Spadoni F; Swan JH; Stefani A
    Brain Res; 2001 Nov; 919(2):259-68. PubMed ID: 11701138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zileuton reduces inflammatory reaction and brain damage following permanent cerebral ischemia in rats.
    Tu XK; Yang WZ; Wang CH; Shi SS; Zhang YL; Chen CM; Yang YK; Jin CD; Wen S
    Inflammation; 2010 Oct; 33(5):344-52. PubMed ID: 20204486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Src family kinase-inhibitor PP2 reduces focal ischemic brain injury.
    Lennmyr F; Ericsson A; Gerwins P; Akterin S; Ahlström H; Terént A
    Acta Neurol Scand; 2004 Sep; 110(3):175-9. PubMed ID: 15285775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.